Abstract
Dystrophin, the missing or defective protein in Duchenne muscular dystrophy, is expressed not only in muscle cells but also in vascular endothelial cells (ECs). In this study, we assessed the effects of dystrophin deficiency on the angiogenic capacities of ECs.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 2867-2876 |
| Numero di pagine | 10 |
| Rivista | Arteriosclerosis, Thrombosis, and Vascular Biology |
| Volume | 33 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- Animals
- Apoptosis
- Aspirin
- Carcinoma, Lewis Lung
- Caveolin 1
- Cell Aging
- Cell Movement
- Cell Proliferation
- Cells, Cultured
- Coculture Techniques
- Corneal Neovascularization
- Cyclic GMP
- Disease Models, Animal
- Dystrophin
- Endothelial Cells
- Endothelium, Vascular
- Ischemia
- Mice
- Mice, Inbred mdx
- Muscular Dystrophy, Duchenne
- Mutation
- Myoblasts, Skeletal
- Neovascularization, Pathologic
- Neovascularization, Physiologic
- Nitric Oxide
- Nitric Oxide Synthase Type III
- Time Factors
- angiogenesis inhibitors
- endothelium, vascular
- muscle diseases, inflammatory
- nitric oxide synthase type III
Fingerprint
Entra nei temi di ricerca di 'Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver